Home › Lung Cancer › Michigan › Canton
Lung Cancer clinical trials in Canton, MI
10 studies for Lung Cancer are looking for participants at sites in and around Canton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RecruitingPhase 3
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
The Vanguard Study: Testing a New Way to Screen for Cancer
RecruitingHealthy volunteers welcome
- Henry Ford Medical Center - Plymouth, Plymouth · 4 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RecruitingPhase 3
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecruitingPhase 2
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA63 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Chicago, IL43 studies
- Arlington, VA42 studies
- Washington, DC41 studies
- Baltimore, MD41 studies
- Nashville, TN39 studies
- St. Louis, MO37 studies
- Columbus, OH36 studies
- Philadelphia, PA36 studies
Other studies in Canton
- Non-Small Cell Lung Cancer9 studies
- Prostate Cancer8 studies
- Acute Myeloid Leukemia7 studies
- Colorectal Cancer6 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
- Ovarian Cancer4 studies
- Bladder Cancer4 studies
- Breast Cancer4 studies
- Chronic Lymphocytic Leukemia3 studies
- Pancreatic Cancer3 studies
- Esophageal Cancer3 studies
- Stomach Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.